Literature DB >> 30138550

Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Smita Jha1,2, Nadja Fratzl-Zelman3, Paul Roschger3, Georgios Z Papadakis4,5, Edward W Cowen6, Heeseog Kang7, Tanya J Lehky8, Katharine Alter9, Zuoming Deng10, Aleksandra Ivovic11, Lauren Flynn12, James C Reynolds13, Abhijit Dasgupta14, Markku Miettinen15, Eileen Lange16, James Katz16, Klaus Klaushofer3, Joan C Marini7, Richard M Siegel11, Timothy Bhattacharyya1.   

Abstract

Melorheostosis is a rare hyperostotic disease of the long bones classically characterized by a "dripping candle-wax" radiographic appearance. We recently described somatic activating mutations in MAP2K1 as a cause of melorheostosis. Here, we report distinguishing characteristics of patients with MAP2K1-positive melorheostosis. Fifteen unrelated patients with radiographic appearance of melorheostosis underwent paired biopsies of affected and unaffected bone for whole-exome sequencing, histology, and cell culture. Eight patients with mutations in MAP2K1 in affected bone were compared to the seven MAP2K1-negative patients to identify distinguishing characteristics. Patients with MAP2K1-positive melorheostosis had a distinct phenotype with classic "dripping candle-wax" appearance on radiographs (p = 0.01), characteristic vascular lesions on skin overlying affected bone (p = 0.01), and higher prevalence of extraosseous mineralization and joint involvement (p = 0.04 for both). Melorheostotic bone from both MAP2K1-positive and MAP2K1-negative patients showed two zones of distinct morphology-an outer segment of parallel layers of primary lamellar bone and a deeper zone of intensely remodeled highly porous osteonal-like bone. Affected bone from MAP2K1-positive patients showed excessive osteoid (p = 0.0012), increased number of osteoblasts (p = 0.012) and osteoclasts (p = 0.04), and increased vascularity on histology in comparison to paired unaffected bone which was not seen in affected bone in most MAP2K1-negative patients. The identification of a distinct phenotype of patients with MAP2K1-positive melorheostosis demonstrates clinical and genetic heterogeneity among patients with the disease. Further studies are needed to better understand the underlying pathophysiology and associated skin findings.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE AND SKIN BIOPSIES; DRIPPING CANDLE-WAX; HISTOLOGY; HYPEROSTOSIS

Mesh:

Substances:

Year:  2018        PMID: 30138550      PMCID: PMC7577747          DOI: 10.1002/jbmr.3577

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

1.  Normative data for iliac bone histomorphometry in growing children.

Authors:  F H Glorieux; R Travers; A Taylor; J R Bowen; F Rauch; M Norman; A M Parfitt
Journal:  Bone       Date:  2000-02       Impact factor: 4.398

2.  Occurrence of osteosarcoma in a melorheostotic femur.

Authors:  M Murphy; S Kearns; M Cavanagh; D O'Connell; B Hurson
Journal:  Ir Med J       Date:  2003-02

3.  Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Authors:  Michael P Whyte; Malachi Griffith; Lee Trani; Steven Mumm; Gary S Gottesman; William H McAlister; Kilannin Krysiak; Robert Lesurf; Zachary L Skidmore; Katie M Campbell; Ilana S Rosman; Susan Bayliss; Vinieth N Bijanki; Angela Nenninger; Brian A Van Tine; Obi L Griffith; Elaine R Mardis
Journal:  Bone       Date:  2017-04-21       Impact factor: 4.398

Review 4.  [Rasopathies: developmental disorders that predispose to cancer and skin manifestations].

Authors:  A Hernández-Martín; A Torrelo
Journal:  Actas Dermosifiliogr       Date:  2011-05-04

5.  Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis.

Authors:  Steven Mumm; Deborah Wenkert; Xiafang Zhang; William H McAlister; Richard J Mier; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

6.  Osteosarcoma arising in a femur with melorheostosis and osteopathia striata.

Authors:  D D Brennan; J F Bruzzi; H Thakore; J C O'Keane; S Eustace
Journal:  Skeletal Radiol       Date:  2002-05-15       Impact factor: 2.199

7.  Cutaneous manifestations of proteus syndrome: correlations with general clinical severity.

Authors:  Diem Nguyen; Joyce T Turner; Cara Olsen; Leslie G Biesecker; Thomas N Darling
Journal:  Arch Dermatol       Date:  2004-08

8.  Malignancies in fibrous dysplasia.

Authors:  P Ruggieri; F H Sim; J R Bond; K K Unni
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

9.  Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?

Authors:  Pascale Chavassieux; Nathalie Portero-Muzy; Jean-Paul Roux; Patrick Garnero; Roland Chapurlat
Journal:  J Clin Endocrinol Metab       Date:  2015-10-27       Impact factor: 5.958

Review 10.  GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2014-11-28       Impact factor: 4.878

View more
  11 in total

1.  Response to: letter to the editor re: Osteoma-like melorheostosis: a rare type of skeletal dysplasia depicted on FDG PET/CT.

Authors:  Alain S Abi-Ghanem; Karl Asmar; Samar Muwakkit; Fouad Boulos
Journal:  Skeletal Radiol       Date:  2020-01       Impact factor: 2.199

2.  Constitutive activation of MEK1 in osteoprogenitors increases strength of bone despite impairing mineralization.

Authors:  John L Fowlkes; R Clay Bunn; Philip D Ray; Evangelia Kalaitzoglou; Sasidhar Uppuganti; Mustafa Unal; Jeffry S Nyman; Kathryn M Thrailkill
Journal:  Bone       Date:  2019-11-02       Impact factor: 4.398

3.  Fibroblasts from Patients with Melorheostosis Promote Angiogenesis in Healthy Endothelial Cells through Secreted Factors.

Authors:  Amelia C Hurley-Novatny; Jules D Allbritton-King; Smita Jha; Edward W Cowen; Robert A Colbert; Fatemeh Navid; Timothy Bhattacharyya
Journal:  J Invest Dermatol       Date:  2022-02-19       Impact factor: 7.590

4.  Occupational engagement, fatigue, and upper and lower extremity abilities in persons with melorheostosis.

Authors:  Kathleen Farrell; Leora E Comis; Morgan M Casimir; Bonnie Hodsdon; Rafael Jiménez-Silva; Tiara Dunigan; Timothy Bhattacharyya; Smita Jha
Journal:  PM R       Date:  2022-04-10       Impact factor: 2.218

5.  Melorheostosis: A Clinical, Pathologic, and Radiologic Case Series.

Authors:  Cameron N Fick; Nadja Fratzl-Zelman; Paul Roschger; Klaus Klaushofer; Smita Jha; Joan C Marini; Timothy Bhattacharyya
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

6.  Clinical Evaluation of Melorheostosis in the Context of a Natural History Clinical Study.

Authors:  Smita Jha; Edward W Cowen; Tanya J Lehky; Katharine Alter; Lauren Flynn; James C Reynolds; Eileen Lange; James D Katz; Joan C Marini; Richard M Siegel; Timothy Bhattacharyya
Journal:  JBMR Plus       Date:  2019-07-26

Review 7.  Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions.

Authors:  Jessica Jann; Suzanne Gascon; Sophie Roux; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

8.  Cross-Sectional Imaging Useful in Melorheostosis.

Authors:  Amelia Hurley-Novatny; Apostolos H Karantanas; Georgios Z Papadakis; Timothy Bhattacharyya; Smita Jha
Journal:  JBMR Plus       Date:  2021-02-18

9.  Distribution and Functional Consequences of Somatic MAP2K1 Variants in Affected Skin Associated with Bone Lesions in Melorheostosis.

Authors:  Smita Jha; Aleksandra Ivovic; Heeseog Kang; Françoise Meylan; Eric P Hanson; Casey Rimland; Eileen Lange; James Katz; Alison McBride; Andrew C Warner; Elijah F Edmondson; Edward W Cowen; Joan C Marini; Richard M Siegel; Timothy Bhattacharyya
Journal:  J Invest Dermatol       Date:  2020-08-11       Impact factor: 8.551

10.  Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway.

Authors:  Heeseog Kang; Smita Jha; Aleksandra Ivovic; Nadja Fratzl-Zelman; Zuoming Deng; Apratim Mitra; Wayne A Cabral; Eric P Hanson; Eileen Lange; Edward W Cowen; James Katz; Paul Roschger; Klaus Klaushofer; Ryan K Dale; Richard M Siegel; Timothy Bhattacharyya; Joan C Marini
Journal:  J Exp Med       Date:  2020-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.